News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteus, S.A. Granted U.S. Patent For Screening Active Compounds Using In Vitro Protein Expression



10/19/2005 5:12:18 PM

Proteus today announced the issuance of a new U.S. Patent addressing the functional screening of candidate active compounds using in vitro protein expression. The patent granted represents the latest addition to Proteus Phenomics(TM) proprietary technology. This embodiment is suited for a broad variety of functional proteomic applications such as activity screening, kinetics or inhibition studies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES